Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,745 | -13,573 | -7,028 | -3,383 | -3,963 |
| Depreciation Amortization | 783 | 590 | 393 | 197 | 906 |
| Accounts receivable | N/A | N/A | -480 | N/A | N/A |
| Other Working Capital | -1,786 | 328 | -1,374 | -193 | 2,431 |
| Other Operating Activity | 1,106 | 837 | 1,159 | 288 | 3,455 |
| Operating Cash Flow | $-17,642 | $-11,818 | $-7,330 | $-3,091 | $2,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -27 | -6 | N/A | -5 |
| Investing Cash Flow | $-42 | $-27 | $-6 | $N/A | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,462 |
| Debt Repayment | N/A | N/A | N/A | N/A | -307 |
| Common Stock Issued | 57,990 | 57,881 | 57,791 | 57,772 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 7,261 |
| Financing Cash Flow | $57,990 | $57,881 | $57,791 | $57,772 | $8,416 |
| Beginning Cash Position | 12,357 | 12,357 | 12,357 | 12,357 | 1,117 |
| End Cash Position | 52,663 | 58,393 | 62,812 | 67,038 | 12,357 |
| Net Cash Flow | $40,306 | $46,036 | $50,455 | $54,681 | $11,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,642 | -11,818 | -7,330 | -3,091 | 2,829 |
| Capital Expenditure | -42 | -27 | -6 | N/A | -5 |
| Free Cash Flow | -17,684 | -11,845 | -7,336 | -3,091 | 2,824 |